Kidneys Home > Polycystic Kidney Disease Research

Treatment
PKD research scientists reported that a cancer drug was successful in inhibiting cyst formation in mice with the PKD gene. Polycystic cancer research scientists also demonstrated that another compound, one that blocks function of a kidney receptor, inhibits cyst formation in mice with the autosomal dominant or autosomal recessive polycystic kidney disease gene. The scientists hope that further testing will lead to safe and effective treatments for humans.
 

Polycystic Kidney Disease Research: Potential Benefits of Participation

In order for polycystic kidney disease research to be conducted, volunteers are needed. Patients who join polycystic kidney disease research studies have the first chance to benefit from polycystic kidney disease treatments that have shown promise in earlier research. They also make an important contribution to medical science by helping doctors learn more about polycystic kidney disease. Although polycystic kidney disease research trials may pose some risks, researchers take very careful steps to protect their patients. Talk to your doctor if you'd like more information about polycystic kidney disease clinical trials.
 
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics & Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.